“突眼”的源头在颈部？专家提示甲状腺眼病要早诊早治

Group 1 - The core issue of thyroid eye disease is its association with thyroid dysfunction, leading to symptoms such as eye bulging, eyelid retraction, and potential vision loss, affecting over 2 million patients in China, with a higher prevalence in women [1] - Early diagnosis and treatment significantly improve the prognosis of thyroid eye disease, with traditional treatment options including corticosteroid injections, orbital radiotherapy, and surgery [1] - The approval of Teprotumumab N01 injection, an IGF-1R antibody drug for treating thyroid eye disease, marks a significant advancement in treatment options, having received regulatory approval in March this year [1] Group 2 - Diagnosis and treatment of thyroid eye disease require a multidisciplinary approach involving endocrinology, ophthalmology, thyroid surgery, radiology, and nuclear medicine [2] - The "Guidelines for the Construction of Standardized Diagnosis and Treatment Centers for Thyroid Eye Disease" emphasize the need for a comprehensive treatment plan that considers disease progression, treatment efficacy, safety, costs, drug accessibility, and patient preferences [2]